TY - CHAP M1 - Book, Section TI - Recommendations About Screening A1 - McCaffery, Kirsten Jo A1 - Jacklyn, Gemma Louise A1 - Barratt, Alexandra A1 - Brodersen, John A1 - Glasziou, Paul A1 - Carter, Stacy M. A1 - Hicks, Nicholas R. A1 - Howard, Kirsten A1 - Irwig, Les A2 - Guyatt, Gordon A2 - Rennie, Drummond A2 - Meade, Maureen O. A2 - Cook, Deborah J. PY - 2015 T2 - Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed AB - CLINICAL SCENARIOYou are a primary care physician advising a 50-year-old woman who is concerned because a friend of hers was recently diagnosed as having breast cancer and has urged her to undergo mammography screening because “it's better to be safe than sorry.”The woman does not have a family history of breast or ovarian cancer or a breast lump. She asks whether you agree that she should undergo screening. You know that trials of mammography screening support both a mortality reduction from breast cancer and the existence of overdetection and false-positive results, which may result in unnecessary investigations and overtreatment. You are unsure of the magnitude of these effects, which you know are crucial in helping your patient to make her decision. To help, you need to know how screening can be evaluated, how screening test results should be interpreted, and whether there are any valid, relevant, and up-to-date clinical practice guidelines or recommendations about screening for breast cancer. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/09 UR - jamaevidence.mhmedical.com/content.aspx?aid=1183878449 ER -